Federal Policy

The White House press secretary said on Friday that President Biden “has always supported the legalization of marijuana for medical purposes” despite having championed legislation that fueled the war on drugs.

In a letter to DEA Administrator Anne Milgram, U.S. Rep. Matt Gaetz (R-FL) asked why the agency has not taken steps to reconsider cannabis’ status as a Schedule I substance.

The U.S. Department of Health and Human Services has recommended that cannabis be moved from a Schedule I to Schedule III substance under federal law.

After a federal appeals court ruled last week that the federal ban on cannabis consumers owning firearms is unconstitutional, the Justice Department informed a separate appeals court that it contests the ruling.

Cannabis research company MMJ International Holdings is preparing a lawsuit against the Drug Enforcement Administration (DEA) for allegedly failing to follow federal law as it concerns the cultivation of pharmaceutical cannabis.

Despite growing momentum for cannabis reforms in Congress, the cannabis industry’s federal lobbying expenditures are down from their peak in previous years.

The U.S. House voted this week to add an amendment to the must-pass federal National Defense Authorization Act (NDAA) that would end the prohibition on VA providers helping veterans to access state-legal medical cannabis programs.

A bipartisan U.S. House proposal seeks to end the consideration of prior or current cannabis use when assigning security clearance for federal employment.

Bipartisan federal lawmakers last week introduced legislation aimed at updating the federal hemp rules to ensure that hemp-derived CBD is regulated by the FDA like other legal products found in dietary supplements, foods, and beverages.

Officials have confirmed that Vermont cannabis businesses are ineligible for federal disaster aid for losses caused by the state’s recent floods because cannabis remains a federally prohibited, Schedule I drug.

Recent amendments to the must-pass National Defense Authorization Act (NDAA) are seeking to end cannabis drug testing at enlistment for new military members.

The U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) this week together issued warning letters to six companies for selling copycat food products containing hemp-derived delta-8 THC.

The American Trade Association for Cannabis and Hemp last week released a policy paper calling on Congress to regulate hemp-derived intoxicants including delta-8 and delta-9 THC products.

A federal House proposal introduced on Tuesday would promote cannabis research at U.S. universities and eliminate federal barriers to cannabis research.

A Pennsylvania proposal would urge the federal government to remove cannabis from the federal Controlled Substances Act, noting that medical cannabis reforms have been enacted in 38 U.S. states and four territories while 21 states, two territories, and Washington D.C. have passed adult-use laws.

The U.S. military and many federal agencies have started to deprioritize prior cannabis use when considering new hires.

Sen. John Tester (D-MT), chairman of the Senate Veterans Affairs Committee, said that a proposal to research medical cannabis use by veterans may be dead following its rejection in the Senate last week.

Bipartisan lawmakers in the U.S. House and Senate reintroduced the SAFE Banking Act this week, which seeks to normalize banking services for state-licensed cannabis companies.

U.S. Rep Brian Mast (R-FL) filed a proposal last week that would end the prohibition of firearm sales to cannabis consumers who are living in states with legal cannabis programs.

A bipartisan House proposal reintroduced this week by Republican Rep. Dave Joyce (OH) and Democratic Leader Hakeem Jeffries (NY) would help prepare the federal government for the end of cannabis prohibition at the national level.

A bipartisan U.S. House proposal filed this week would exempt state-legal cannabis companies from the restrictions of IRS Code 280E, which has vexed modern cannabis operators for years.

A bipartisan proposal by U.S. Sens. John Tester (D-MT) and Mike Braun (R-IN) is seeking to reduce regulations for hemp farmers producing grain and fiber.

The Psychedelic Medicine PAC is a newly-formed political action committee that will back candidates who support the use of psychedelics for therapeutic purposes.